Pharmaceutical Industry Information Portal

HomeNews

News

Sputnik V has demonstrated 97.8% efficacy against COVID-19 in UAE

Efficacy among more than 81,000 subjects who had received both components of Sputnik V was 97.8%. Analysis is based on the data collected by June 8, 2021.

VTB Capital invests in Binnopharm Group

VTB Capital has invested in the pharmaceutical holding company Binnopharm Group. Sistema’s wholly-owned subsidiary LLC Sistema Telecom Assets sold an 11.2% stake in Ristango...

Johnson & Johnson agrees to pay $263m to settle NY opioid claims, exits market

Johnson & Johnson has shaken off another lingering liability claim in the US, agreeing a $263 million settlement with New York to resolve lawsuits...

WHO, WIPO, WTO map out further collaboration to tackle COVID-19 pandemic

The Directors-General of the World Health Organization (WHO), the World Intellectual Property Organization (WIPO) and the WTO agreed to enhance their support to members...

Test batch of the Sputnik V vaccine produced in Iran

The production of Sputnik V, a vaccine for the coronavirus developed by Russia, began at an Iranian company on Saturday, 26 June. In a...

COVID-19 vaccine technology transfer hub to be set up in South Africa

The World Health Organization (WHO) and its COVAX partners are working with a South African consortium comprising Biovac, Afrigen Biologics and Vaccines, a network of universities...
spot_img

Expert Articles

spot_img